Stratification of patients based on their CD47 and CD24 expression levels demonstrated a significant correlation with improved overall survival in individuals with lower CD47 expression among PC patients and lower CD24 expression among BC patients (Supplementary Fig. 17e, f). The gene discussed is CD47; the disease is breast cancer.